Surgery Partners, Inc.
SGRY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $25,300 | $0 | -$300 | -$46,600 |
| Dep. & Amort. | $39,500 | $0 | $36,300 | $33,900 |
| Deferred Tax | $5,100 | $0 | -$300 | $121,200 |
| Stock-Based Comp. | $2,600 | $0 | $7,600 | $6,200 |
| Change in WC | -$18,400 | -$16,700 | -$56,900 | -$31,500 |
| Other Non-Cash | $29,500 | $98,000 | $19,600 | $28,200 |
| Operating Cash Flow | $83,600 | $81,300 | $6,000 | $111,400 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$19,800 | -$23,400 | -$22,700 | -$22,300 |
| Net Acquisitions | -$800 | -$4,000 | -$44,000 | -$87,000 |
| Inv. Purchases | $0 | $0 | -$3,800 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$25,600 | $29,500 | -$5,900 | -$2,400 |
| Investing Cash Flow | -$46,200 | $2,100 | -$76,400 | -$111,700 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$33,100 | -$11,500 | $94,300 | $95,400 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$51,000 | -$51,100 | -$64,100 | -$47,400 |
| Financing Cash Flow | -$84,100 | -$62,600 | $30,200 | $48,000 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$46,700 | $20,800 | -$40,200 | $47,700 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $250,100 | $229,300 | $269,500 | $221,800 |
| End Cash | $203,400 | $250,100 | $229,300 | $269,500 |
| Free Cash Flow | $63,800 | $57,900 | -$16,700 | $89,100 |